Recent Advances in Bioelectronics Medicine

Rapid advances in electronics, sensors, computation, wireless systems, artificial intelligence, and neurotechnology are creating a new generation of medical solutions that interact directly with the body’s electrical and physiological control systems. Collectively described as bioelectronic medicine, these technologies offer the potential to complement—and in some applications overcome important limitations of—traditional pharmaceutical approaches by providing interventions that can be spatially targeted, dynamically adjusted, continuously monitored, and personalized to an individual patient’s physiology.

This Master Class will provide a broad introduction to the rapidly evolving field of bioelectronic medicine from the perspective of electrical and computer engineering. It will examine how technologies familiar to engineers—including low-noise sensing, embedded computing, signal processing, machine learning, wireless communications, miniaturized stimulation electronics, wearable devices, and closed-loop control—are being translated into new diagnostic and therapeutic platforms. Examples will range from cardiac pacemakers and cochlear implants to deep-brain stimulation, vagus nerve stimulation, spinal cord stimulation, transcranial stimulation, peripheral nerve interfaces, and digital biomarkers. Particular attention will be given to the transition from open-loop stimulation toward sensor-guided, closed-loop bioelectronic medicine, in which physiological measurements provide real-time feedback for optimizing stimulation parameters and tracking therapeutic responses. 
The Master Class will also explore why engineers are increasingly central to the future of medicine. Biological systems present unusual engineering challenges: signals are weak and noisy, anatomy and physiology vary substantially between individuals, neural systems are nonlinear and adaptive, and successful devices must operate safely at the interface between electronics and living tissue. These challenges are generating opportunities for innovation across semiconductor technology, MEMS and wearable sensors, electrode design, power management, computational modeling, AI, cybersecurity, human-machine interfaces, and systems engineering.

The Master Class will conclude with a look toward the next generation of bioelectronic medicine: intelligent therapeutic systems and digital twins capable not simply of measuring disease or delivering predetermined stimulation, but of continuously sensing physiological state, interpreting changes in biological function, and adapting interventions to promote recovery and maintain health. For electrical and computer engineers, this emerging field represents an opportunity to apply core engineering disciplines to some of the most consequential challenges in human health.
 

ABOUT THE SPEAKER

John Ralston, PhD, CEO and Co-founder, Neursantys Inc. 
John Ralston is a pioneer in the development of non-invasive bioelectronic devices and adaptive neuroplastic treatments for neurosensory, neuromotor, and neurocognitive impairments that have limited pharmacological treatment options. 

At Neursantys, John is collaborating with healthcare researchers, providers, and payers to restore motor and cognitive functions that have been impaired by both normal aging and accelerated aging caused by head trauma, disease, and spaceflight. 

With a career spanning public and private R&D organizations and entrepreneurial ventures in Canada, Europe, and the U.S., John has authored/co-authored over 250 professional publications, presented over 150 talks and seminars, and has 16 issued patents. John earned B.Sc. degrees in Physics and Electrical Engineering from M.I.T., a PhD in Electrical Engineering from Cornell University, and the MSc in Management of Technology from the MIT Sloan School of Management.